Abbott Wins U.S. Approval for HIV Viral Load Test
May 15, 2007
On Friday, Abbott Laboratories Inc. said it had gained US approval for a viral load test for blood samples in automated lab systems. The RealTime HIV-1 viral load test was developed for use with Abbott's m2000 system, which performs DNA and RNA testing to help assess HIV/AIDS treatment. Abbott and Celera Group Inc. jointly market the m2000 system worldwide.
Thailand Will Not Issue Compulsory Licenses for Patented Drugs if Pharmaceutical Companies Match Generic Prices, Health Minister Says
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.